IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rstctd - Cure Pharmaceutical H

Q2 2017 vs Q3 2017

Comparing institutional holders between quarters

Quarters

Q3 2017Q2 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Private Capital Advisors, Inc.
UNCHANGED
Shares250,000 from 250,000
Change0 (0%)
Value$1.4K (-$625)
Filed 2017-10-18
Status
Private Capital Advisors, Inc.
UNCHANGED250,000250,00000%$2.0K$1.4K-$6252017-10-18
Showing 1 of 1 institutions